Use of Apremilast in Patients With Psoriatic Arthritis During the COVID-19 Pandemic: Comment on the Article by Mikuls et al

Arthritis Rheumatol. 2021 Mar;73(3):547-548. doi: 10.1002/art.41575. Epub 2021 Jan 29.

Authors

Pankaj Bansal¹, Amandeep Goyal², Austin Cusick³, Fawad Aslam⁴

Affiliations

¹ Mayo Clinic Health System, Eau Claire, WI.
² University of Kansas Medical Center, Kansas City, KS.
³ Ohio University Heritage College of Osteopathic Medicine, Athens, OH.
⁴ Mayo Clinic, Scottsdale, AZ.

PMID: 33142038
DOI: 10.1002/art.41575

No abstract available

Publication types

Letter
Comment

MeSH terms

Adult
Arthritis, Psoriatic* / drug therapy
COVID-19*
Humans
Pandemics
Rheumatic Diseases*
Rheumatology*
SARS-CoV-2
Thalidomide / analogs & derivatives
United States

Substances

Thalidomide
apremilast